# Captopril Versus Atenolol to Prevent Expansion Rate of Thoracic Aortic Aneurysms

> **NCT04224675** · NA · UNKNOWN · sponsor: **Onassis Cardiac Surgery Centre** · enrollment: 424 (estimated)

## Conditions studied

- Aneurysm

## Interventions

- **DRUG:** Atenolol

## Key facts

- **NCT ID:** NCT04224675
- **Lead sponsor:** Onassis Cardiac Surgery Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-07
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-03-07
- **Target enrollment:** 424 (ESTIMATED)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224675, "Captopril Versus Atenolol to Prevent Expansion Rate of Thoracic Aortic Aneurysms". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04224675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*